Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qigui FUYUAN decoction is a Traditional Chinese Medicine (TCM) herbal formula being investigated for its potential in post-stroke rehabilitation and the prevention of recurrence in patients with ischemic stroke. The decoction typically contains key botanical ingredients such as *Astragalus membranaceus* (Huangqi) and *Angelica sinensis* (Danggui), which are traditionally used in TCM to tonify Qi and invigorate blood circulation. In the context of ischemic stroke, the formula is hypothesized to address the 'Qi deficiency and blood stasis' pattern, thereby improving neurological function, enhancing physical recovery, and reducing the risk of secondary vascular events. Clinical evaluation of the decoction is supported by the Department of Science and Technology of Hainan Province, with studies often conducted at the Hainan Provincial Hospital of Traditional Chinese Medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qigui FUYUAN decoction.